The use of indexes in the interpretation of cerebrospinal fluid analyses.
Verbeek
Marcel M
MM
Radboud University Nijmegen Medical Centre, Department of Neurology, Nijmegen, The Netherlands. m.verbeek@neuro.umcn.nl
Sjögren
J Magnus C
JM
D000368:Aged; D000544:Alzheimer Disease / Q000097:blood / Q000134:cerebrospinal fluid* / Q000150:complications; D016229:Amyloid beta-Peptides / Q000378:metabolism; D000704:Analysis of Variance; D015415:Biomarkers / Q000097:blood / Q000134:cerebrospinal fluid; D002097:C-Reactive Protein / Q000378:metabolism; D003072:Cognition Disorders / Q000097:blood* / Q000134:cerebrospinal fluid* / Q000150:complications; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015850:Interleukin-6 / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D010446:Peptide Fragments / Q000378:metabolism; D012189:Retrospective Studies; D000515:alpha 1-Antitrypsin / Q000378:metabolism; D016875:tau Proteins / Q000378:metabolism
D016229:Amyloid beta-Peptides; D015415:Biomarkers; D015850:Interleukin-6; D010446:Peptide Fragments; D000515:alpha 1-Antitrypsin; C075222:amyloid beta-protein (1-42); D016875:tau Proteins; D002097:C-Reactive Protein